Find Clinical Trial

Clinical efficacy of VALDOXAN in everyday practice conditions (efficiency) in depressed patients, on a treatment-naive or switch basis. Phase-IV, multicentre, open, interventional clinical study. VALDOXAN D-CHANGE Study


← Back
Study Phase

Phase 4

Therapeutic Area

Neuropsychiatric Diseases

Active substance/
Medical device

S020098, AGOMELATINE

SponsorEUTHERAPIE / Les Laboratoires Servier
Active Substance CodeS020098
Protocol CodeDM4-20098-108
EudraCT Code2008-008220-32
ISRCTN CodeISRCTN68100949


Documents and links

Results summary READ MORE




Servier Glossary of Terms

To ease the reading, we are developing a glossary of terms. In this glossary, we provide the lay terms used in our lay summaries and the corresponding medical terms. You will find the Servier Glossary of Terms on this link.



© 2017 LES LABORATOIRES SERVIER, an incorporated company of Servier.
All Rights Reserved. Servier does not sell its products over the Internet.
More information

Report a side-effect with a drug.
Accessibility